Hypopigmented Junctional BAP1‐Inactivated Melanocytoma: A Paradigm Shift
Since their original description by Wiesner et al., the spectrum of clinical, histopathologic, and molecular findings of BAP1 (BRCA1-associated protein 1)-inactivated melanocytomas has been more fully characterized. Herein, we report an exceptional presentation of multiple junctional melanocytic BAP1-inactivated melanocytomas with a clinically hypopigmented appearance in a patient. Targeted DNA sequencing demonstrated the same BAP1 frameshift mutation (BAP1 p.R59f) in three different lesions. One of the specimens also displayed two truncating mutations in NF1 (NF1 p.Q129* and NF1 p.Q1801*) at 8%-9% mutant allele frequency. To our knowledge, BIM confined entirely to the epidermis, and multiple BIMs presenting in hypopigmented fashion have not been widely reported previously.
Authors
- Timothy H. McCalmont (ORCID: https://orcid.org/0000-0002-8102-3348)
- Ali Noel Gunesch
- Gretchen E. Vanderbeek
- Elizabeth Berry (ORCID: https://orcid.org/0000-0002-7574-6718)
- Iwei Yeh (ORCID: https://orcid.org/0000-0002-3941-3561)
- Kevin P. White (ORCID: https://orcid.org/0000-0002-2450-1243)
Institutions
- Oregon Health & Science University (US)
- Tigard-Tualatin School District (US)
- University of California San Francisco Medical Center (US)
Publication Details
- Journal
- Journal of Cutaneous Pathology
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1111/cup.14808
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00